Millennium Management LLC bought a new stake in Calyxt Inc (NASDAQ:CLXT) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 31,197 shares of the company’s stock, valued at approximately $582,000. Millennium Management LLC owned approximately 0.10% of Calyxt as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently made changes to their positions in CLXT. FMR LLC boosted its stake in Calyxt by 40.2% in the second quarter. FMR LLC now owns 4,799,299 shares of the company’s stock valued at $89,603,000 after acquiring an additional 1,375,899 shares in the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Calyxt during the second quarter worth $5,601,000. Columbus Hill Capital Management L.P. acquired a new stake in shares of Calyxt during the second quarter worth $3,124,000. BlackRock Inc. lifted its stake in shares of Calyxt by 21.8% during the second quarter. BlackRock Inc. now owns 733,554 shares of the company’s stock worth $13,696,000 after buying an additional 131,265 shares during the period. Finally, Laurion Capital Management LP acquired a new stake in shares of Calyxt during the second quarter worth $1,150,000. Institutional investors own 28.30% of the company’s stock.
CLXT has been the subject of several research reports. Zacks Investment Research downgraded shares of Calyxt from a “buy” rating to a “hold” rating in a research note on Monday, November 19th. Goldman Sachs Group initiated coverage on shares of Calyxt in a research note on Friday, September 7th. They set a “neutral” rating and a $18.00 price objective for the company. Citigroup decreased their target price on shares of Calyxt from $19.00 to $13.00 and set a “neutral” rating for the company in a research report on Monday, November 19th. Finally, Jefferies Financial Group restated a “buy” rating and set a $27.00 target price on shares of Calyxt in a research report on Thursday, November 15th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Calyxt has a consensus rating of “Buy” and a consensus price target of $21.05.
Calyxt (NASDAQ:CLXT) last released its quarterly earnings data on Wednesday, November 14th. The company reported ($0.23) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.06. Calyxt had a negative net margin of 6,256.67% and a negative return on equity of 33.08%. The company had revenue of $0.03 million during the quarter, compared to analysts’ expectations of $0.50 million. Research analysts expect that Calyxt Inc will post -0.93 earnings per share for the current year.
In other Calyxt news, insider Daniel F. Voytas sold 4,666 shares of Calyxt stock in a transaction on Thursday, September 20th. The shares were sold at an average price of $16.00, for a total value of $74,656.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Manoj Sahoo sold 2,521 shares of the business’s stock in a transaction dated Monday, October 1st. The stock was sold at an average price of $14.84, for a total transaction of $37,411.64. The disclosure for this sale can be found here. Insiders sold 20,553 shares of company stock valued at $303,275 in the last ninety days. 2.80% of the stock is owned by corporate insiders.
WARNING: This news story was originally published by Baseball Daily News and is owned by of Baseball Daily News. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://www.baseballdailydigest.com/news/2018/12/03/millennium-management-llc-invests-582000-in-calyxt-inc-clxt-stock.html.
Calyxt Company Profile
Calyxt, Inc, a consumer-centric food- and agriculture-focused company, develops healthier specialty food ingredients and food crops using gene-editing technology for plants in the United States. It engages in the development of high oleic soybeans, high fiber wheat, herbicide tolerant wheat, powdery mildew resistant wheat, improved oil composition canola, herbicide tolerant canola, improved quality alfalfa and herbicide tolerant alfalfa, late blight resistant potatoes, cold storable/reduced browning potatoes, improved protein composition soybeans, drought tolerant soybeans, herbicide tolerant soybeans, and improved yield soybeans.
Featured Article: Google Finance Portfolio Tips and Tricks
Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.